JPMorgan downgraded aTyr Pharma (NASDAQ: LIFE) from Neutral to Underweight.Analyst Cory Kasimov remains optimistic on biotech ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE